{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:34:24Z","timestamp":1789576464675,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>FAM210B (family with sequence similarity 210 member B) is a novel protein that has been linked to tumor development. However, its role and underlying mechanisms in lung adenocarcinoma (LUAD) progression remain largely unexplored. In this study, FAM210B was observed to be down-regulated in LUAD cells. Analyses of public datasets revealed that decreased expression of FAM210B predicts poor survival. Accordingly, in vitro and in vivo studies have confirmed the inhibitory role of FAM210B on the growth and tumor metastasis of LUAD cells. RNA-seq analysis further indicated that FAM210B plays a role in regulating innate immune-related signaling pathways in LUAD cells, particularly involving the production of type I interferon (IFN-\u03b1\/\u03b2). Specifically, FAM210B activates STAT1\/IRF9\/IFIT3 axis by upregulating IFN-\u03b1\/\u03b2 expression, leading to the inhibition of proliferation and migration of LUAD cells. Furthermore, TOM70 (Translocase of outer mitochondrial membrane 70, also named as TOMM70) has been identified as a functional interacting partner of FAM210B in its modulation on the expression of IFN-\u03b1\/\u03b2, as well as the proliferative and metastatic phenotypes of LUAD cells. In conclusion, our study indicates that FAM210B is an important suppressor of cellular viability and mobility during lung cancer progression.<\/jats:p>","DOI":"10.1038\/s41419-025-07375-9","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:39:58Z","timestamp":1738586398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["FAM210B activates STAT1\/IRF9\/IFIT3 axis by upregulating IFN-\u03b1\/\u03b2 expression to impede the progression of lung adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-4714","authenticated-orcid":false,"given":"Xuejuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiye","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Ming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-8195","authenticated-orcid":false,"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-3433","authenticated-orcid":false,"given":"Gong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-255X","authenticated-orcid":false,"given":"Wanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7847-2804","authenticated-orcid":false,"given":"Langxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"7375_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/ijms21041193","volume":"21","author":"XN Lai","year":"2020","unstructured":"Lai XN, Li J, Tang LB, Chen WT, Zhang L, Xiong LX. MiRNAs and LncRNAs: dual roles in TGF-beta signaling-regulated metastasis in lung cancer. Int J Mol Sci. 2020;21:1193.","journal-title":"Int J Mol Sci"},{"key":"7375_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"7375_CR3","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/onc.2016.149","volume":"35","author":"S Yuan","year":"2016","unstructured":"Yuan S, Yu Z, Liu Q, Zhang M, Xiang Y, Wu N, et al. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt\/beta-catenin signaling in lung adenocarcinoma. Oncogene. 2016;35:6120\u201331.","journal-title":"Oncogene"},{"key":"7375_CR4","first-page":"71","volume":"316","author":"G Uze","year":"2007","unstructured":"Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol. 2007;316:71\u201395.","journal-title":"Curr Top Microbiol Immunol"},{"key":"7375_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8:204.","journal-title":"Signal Transduct Target Ther"},{"key":"7375_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/cr.2016.149","volume":"27","author":"L Corrales","year":"2017","unstructured":"Corrales L, Matson V, Flood B, Spranger S, Gajewski TF. Innate immune signaling and regulation in cancer immunotherapy. Cell Res. 2017;27:96\u2013108.","journal-title":"Cell Res"},{"key":"7375_CR7","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.cell.2023.02.039","volume":"186","author":"OK Dagher","year":"2023","unstructured":"Dagher OK, Schwab RD, Brookens SK, Posey AD Jr. Advances in cancer immunotherapies. Cell. 2023;186:1814\u2013e1.","journal-title":"Cell"},{"key":"7375_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou Z, Ghosh K, Vizioli MG, Zhu J, Sen P, Wangensteen KJ, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550:402\u20136.","journal-title":"Nature"},{"key":"7375_CR9","first-page":"365","volume":"45","author":"I Gresser","year":"1970","unstructured":"Gresser I, Bourali C. Antitumor effects of interferon preparations in mice. J Natl Cancer Inst. 1970;45:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"7375_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1039260","volume":"13","author":"C Lu","year":"2022","unstructured":"Lu C, Liu Y, Ali NM, Zhang B, Cui X. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. Front Immunol. 2022;13:1039260.","journal-title":"Front Immunol"},{"key":"7375_CR11","doi-asserted-by":"publisher","first-page":"e1314424","DOI":"10.1080\/2162402X.2017.1314424","volume":"6","author":"M Musella","year":"2017","unstructured":"Musella M, Manic G, De Maria R, Vitale I, Sistigu A. Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications. Oncoimmunology. 2017;6:e1314424.","journal-title":"Oncoimmunology"},{"key":"7375_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1021\/acs.jproteome.2c00412","volume":"22","author":"X Gao","year":"2023","unstructured":"Gao X, Lian Q, Guan B, Liu QY, Meng M, Chen Y, et al. ZSWIM1 promotes the proliferation and metastasis of lung adenocarcinoma cells through the STK38\/MEKK2\/ERK1\/2 axis. J Proteome Res. 2023;22:1080\u201391.","journal-title":"J Proteome Res"},{"key":"7375_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.796","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang J, Zheng CC, Huang ZJ, Zhang WX, Long YL, et al. C20orf24 promotes colorectal cancer progression by recruiting Rin1 to activate Rab5-mediated mitogen-activated protein kinase\/extracellular signal-regulated kinase signalling. Clin Transl Med. 2022;12:e796.","journal-title":"Clin Transl Med"},{"key":"7375_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12185-016-1968-4","volume":"103","author":"A Kondo","year":"2016","unstructured":"Kondo A, Fujiwara T, Okitsu Y, Fukuhara N, Onishi Y, Nakamura Y, et al. Identification of a novel putative mitochondrial protein FAM210B associated with erythroid differentiation. Int J Hematol. 2016;103:387\u201395.","journal-title":"Int J Hematol"},{"key":"7375_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.273","volume":"8","author":"S Sun","year":"2017","unstructured":"Sun S, Liu J, Zhao M, Han Y, Chen P, Mo Q, et al. Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming. Cell Death Dis. 2017;8:e2870.","journal-title":"Cell Death Dis"},{"key":"7375_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/biomedicines11041232","volume":"11","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Pan X, Liu Y, Li X, Lin K, Zhu J, et al. Loss of the Novel Mitochondrial Membrane Protein FAM210B Is Associated with Hepatocellular Carcinoma. Biomedicines. 2023;11:1232.","journal-title":"Biomedicines"},{"key":"7375_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40425-018-0408-9","volume":"6","author":"P Friedlander","year":"2018","unstructured":"Friedlander P, Wood K, Wassmann K, Christenfeld AM, Bhardwaj N, Oh WK. A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab. J Immunother Cancer. 2018;6:90.","journal-title":"J Immunother Cancer"},{"key":"7375_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10549-019-05307-8","volume":"177","author":"C Plasterer","year":"2019","unstructured":"Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O\u2019Meara C, Sun Y, et al. Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. Breast Cancer Res Treat. 2019;177:77\u201391.","journal-title":"Breast Cancer Res Treat"},{"key":"7375_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03364-2","volume":"12","author":"HT Zhang","year":"2021","unstructured":"Zhang HT, Zeng Q, Wu B, Lu J, Tong KL, Lin J, et al. TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy. Cell Death Dis. 2021;12:21.","journal-title":"Cell Death Dis"},{"key":"7375_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep22999","volume":"6","author":"X Gao","year":"2016","unstructured":"Gao X, Feng J, He Y, Xu F, Fan X, Huang W, et al. hnRNPK inhibits GSK3beta Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells. Sci Rep. 2016;6:22999.","journal-title":"Sci Rep"},{"key":"7375_CR21","doi-asserted-by":"publisher","first-page":"D206","DOI":"10.1093\/nar\/gkx1034","volume":"46","author":"W Liu","year":"2018","unstructured":"Liu W, Xiang L, Zheng T, Jin J, Zhang G. TranslatomeDB: a comprehensive database and cloud-based analysis platform for translatome sequencing data. Nucleic Acids Res. 2018;46:D206\u2013D12.","journal-title":"Nucleic Acids Res"},{"key":"7375_CR22","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1021\/acs.jproteome.8b00352","volume":"17","author":"D Li","year":"2018","unstructured":"Li D, Lu S, Liu W, Zhao X, Mai Z, Zhang G. Optimal settings of mass spectrometry open search strategy for higher confidence. J Proteome Res. 2018;17:3719\u201329.","journal-title":"J Proteome Res"},{"key":"7375_CR23","first-page":"186","volume":"31","author":"QZ Zeng","year":"2018","unstructured":"Zeng QZ, Liu WT, Lu JL, Liu XH, Zhang YF, Liu LX, et al. YWHAZ binds to TRIM21 but is not involved in TRIM21-stimulated osteosarcoma cell proliferation. Biomed Environ Sci. 2018;31:186\u201396.","journal-title":"Biomed Environ Sci"},{"key":"7375_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41420-022-01215-x","volume":"8","author":"X Liu","year":"2022","unstructured":"Liu X, Li L, Geng C, Wen S, Zhang C, Deng C, et al. DDX17 promotes the growth and metastasis of lung adenocarcinoma. Cell Death Discov. 2022;8:425.","journal-title":"Cell Death Discov"},{"key":"7375_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"EA Collisson","year":"2014","unstructured":"Collisson EA, Campbell JD, Brooks AN, Berger AH, Lee W, Chmielecki J, et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543\u201350.","journal-title":"Nature"},{"key":"7375_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2174\/092986707780597907","volume":"14","author":"SG Maher","year":"2007","unstructured":"Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM. Interferon: cellular executioner or white knight? Curr Med Chem. 2007;14:1279\u201389.","journal-title":"Curr Med Chem"},{"key":"7375_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/CJI.0b013e3181ad4092","volume":"32","author":"T Tsuno","year":"2009","unstructured":"Tsuno T, Mejido J, Zhao T, Schmeisser H, Morrow A, Zoon KC. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha. J Immunother. 2009;32:803\u201316.","journal-title":"J Immunother"},{"key":"7375_CR28","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/cr.2010.103","volume":"20","author":"XY Liu","year":"2010","unstructured":"Liu XY, Wei B, Shi HX, Shan YF, Wang C. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res. 2010;20:994\u20131011.","journal-title":"Cell Res"},{"key":"7375_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000336490","volume":"82","author":"S Aoyagi","year":"2012","unstructured":"Aoyagi S, Hata H, Homma E, Shimizu H. Sequential local injection of low-dose interferon-beta for maintenance therapy in stage II and III melanoma: a single-institution matched case-control study. Oncology. 2012;82:139\u201346.","journal-title":"Oncology"},{"key":"7375_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/cyto.2002.1028","volume":"18","author":"H Satomi","year":"2002","unstructured":"Satomi H, Wang B, Fujisawa H, Otsuka F. Interferon-beta from melanoma cells suppresses the proliferations of melanoma cells in an autocrine manner. Cytokine. 2002;18:108\u201315.","journal-title":"Cytokine"},{"key":"7375_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1365-2230.2009.03207.x","volume":"34","author":"T Fujimura","year":"2009","unstructured":"Fujimura T, Okuyama R, Ohtani T, Ito Y, Haga T, Hashimoto A, et al. Perilesional treatment of metastatic melanoma with interferon-beta. Clin Exp Dermatol. 2009;34:793\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"7375_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2017.06.072","volume":"490","author":"J Uehara","year":"2017","unstructured":"Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, et al. Intratumoral injection of IFN-beta induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. Biochem Biophys Res Commun. 2017;490:521\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"7375_CR33","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/sj.onc.1205341","volume":"21","author":"S Huang","year":"2002","unstructured":"Huang S, Bucana CD, Van Arsdall M, Fidler IJ. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene. 2002;21:2504\u201312.","journal-title":"Oncogene"},{"key":"7375_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.7150\/thno.51245","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, et al. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Theranostics. 2021;11:1473\u201392.","journal-title":"Theranostics"},{"key":"7375_CR35","first-page":"19","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu Z. STAT1 in cancer: friend or foe? Discov Med. 2017;24:19\u201329.","journal-title":"Discov Med"},{"key":"7375_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13046-019-1479-2","volume":"38","author":"M Yan","year":"2019","unstructured":"Yan M, Sun L, Li J, Yu H, Lin H, Yu T, et al. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer. J Exp Clin Cancer Res. 2019;38:478.","journal-title":"J Exp Clin Cancer Res"},{"key":"7375_CR37","first-page":"6540","volume":"61","author":"KE Luker","year":"2001","unstructured":"Luker KE, Pica CM, Schreiber RD, Piwnica-Worms D. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer Res. 2001;61:6540\u20137.","journal-title":"Cancer Res"},{"key":"7375_CR38","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1073\/pnas.0308102100","volume":"101","author":"NN Khodarev","year":"2004","unstructured":"Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA. 2004;101:1714\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7375_CR39","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1002\/ijc.29161","volume":"136","author":"I Kolosenko","year":"2015","unstructured":"Kolosenko I, Fryknas M, Forsberg S, Johnsson P, Cheon H, Holvey-Bates EG, et al. Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. Int J Cancer. 2015;136:E51\u201361.","journal-title":"Int J Cancer"},{"key":"7375_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/cancers13020208","volume":"13","author":"D Brunn","year":"2021","unstructured":"Brunn D, Turkowski K, Gunther S, Weigert A, Muley T, Kriegsmann M, et al. Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican. Cancers. 2021;13:208.","journal-title":"Cancers"},{"key":"7375_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/cancers14040919","volume":"14","author":"BR Sharma","year":"2022","unstructured":"Sharma BR, Karki R, Sundaram B, Wang Y, Vogel P, Kanneganti TD. The transcription factor IRF9 promotes colorectal cancer via modulating the IL-6\/STAT3 signaling axis. Cancers. 2022;14:919.","journal-title":"Cancers"},{"key":"7375_CR42","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1530\/ERC-13-0222","volume":"20","author":"HH Erb","year":"2013","unstructured":"Erb HH, Langlechner RV, Moser PL, Handle F, Casneuf T, Verstraeten K, et al. IL6 sensitizes prostate cancer to the antiproliferative effect of IFNalpha2 through IRF9. Endocr Relat Cancer. 2013;20:677\u201389.","journal-title":"Endocr Relat Cancer"},{"key":"7375_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2008.09.004","volume":"14","author":"M De Palma","year":"2008","unstructured":"De Palma M, Mazzieri R, Politi LS, Pucci F, Zonari E, Sitia G, et al. Tumor-targeted interferon-\u03b1 delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell. 2008;14:299\u2013311.","journal-title":"Cancer Cell"},{"key":"7375_CR44","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI37223","volume":"120","author":"J Jablonska","year":"2010","unstructured":"Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S. Neutrophils responsive to endogenous IFN-\u03b2 regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Investig. 2010;120:1151\u201364.","journal-title":"J Clin Investig"},{"key":"7375_CR45","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1128\/JVI.76.11.5532-5539.2002","volume":"76","author":"N Grandvaux","year":"2002","unstructured":"Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol. 2002;76:5532\u20139.","journal-title":"J Virol"},{"key":"7375_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23118-8","volume":"12","author":"X Gao","year":"2021","unstructured":"Gao X, Zhu K, Qin B, Olieric V, Wang M, Cui S. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions. Nat Commun. 2021;12:2843.","journal-title":"Nat Commun"},{"key":"7375_CR47","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1128\/JVI.02959-14","volume":"89","author":"B Wei","year":"2015","unstructured":"Wei B, Cui Y, Huang Y, Liu H, Li L, Li M, et al. Tom70 mediates Sendai virus-induced apoptosis on mitochondria. J Virol. 2015;89:3804\u201318.","journal-title":"J Virol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07375-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:42:03Z","timestamp":1738586523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7375"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07375-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"26 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}